title: [Adoptive immunotherapy of malignancies].
abstract: The results of the studies show that mononuclear leukocytes isolated from human peripheral blood, malignant effusions, and surgically removed spleen can be generated into lymphokine-activated killers (LAK) characterized by high anti-tumor activity. LAKs may be used foradoptive immunotherapy of malignant effusions and the prevention of tumor recurrence in oncological patients after radical surgery.
authors: I Zh
authors: IZh
authors: Shubina
authors: A G
authors: AG
authors: Bliumenberg
authors: S M
authors: SM
authors: Volkov
authors: L V
authors: LV
authors: Demidov
authors: M V
authors: MV
authors: Kiselevskiĭ
mesh_terms: D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008854:Microscopy, Electron; D009369:Neoplasms / Q000628:therapy* / Q000648:ultrastructure*